Protagenic Therapeutics Inc (NASDAQ:PTIX)
| 0.7325 Delayed Data As of Nov 30 |  +0.015 / +2.00%Today’s Change | 0.71 Today|||52-Week Range 2.52 | -54.22% Year-to-Date |
Latest PTIX News | Press Releases
No recent news for Protagenic Therapeutics Inc.
Today’s Trading
| Previous close | 0.75 |
| Today’s open | 0.78 |
| Day’s range | 0.75 - 0.78 |
| Volume | 1,678 |
| Average volume (3 months) | 12,346 |
| Market cap | $23.2M |
Data as of 3:25pm ET, 11/30/2023
Growth & Valuation
| Earnings growth (last year) | +32.91% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CYCCCyclacel Pharmaceuti... | -0.03 | -10.03% |
| NBSENeuBase Therapeutics... | -0.08 | -7.75% |
| ---- | ||
| CYCCPCyclacel Pharmaceuti... | +0.05 | +0.55% |
Data as of 3:59pm ET, 12/01/2023
Financials
| Last reporting date | April 7, 2022 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$3.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
